OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
OOA$39.6057

Octopus AIM VCT PLC

Investment Management & Fund OperatorsVerified

The company maintains a strong liquidity position, with a current ratio of 7.11, indicating that it has significantly more current assets than current liabilities. It holds £18.2 million in cash and equivalents, which supports its liquidity profile. However, the company's price-to-book ratio is 86.0, suggesting that the market value is significantly higher than the book value, which may reflect investor sentiment or speculative positioning. Profitability metrics are negative, with a return on equity of -5.27% and a return on assets of -5.03%. These figures indicate that the company is not generating returns for its shareholders and is underperforming relative to industry norms. The company's operating and net income are both negative, at -£6.08 million, which suggests that it is not currently profitable and is likely relying on capital gains or other non-operational sources to sustain its operations. The company's revenue is reported as negative (-£3.35 million), which is unusual and may indicate a reporting anomaly or a specific accounting treatment. The company's investment portfolio spans multiple sectors, including software and computer services, pharmaceuticals and biotechnology, and telecommunications service providers, among others. However, the input data does not provide specific revenue concentration figures, so it is unclear whether the company has significant exposure to any particular segment or geographic region. The company's growth trajectory is not clearly defined in the input data, as there are no forward-looking revenue projections or historical growth rates provided. The company's current financial performance is negative, and there is no indication of a turnaround in the near term. The company's investment strategy is focused on long-term capital growth, but the current financial results suggest that it is not achieving this objective. The company's risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company has no long-term debt, which reduces its financial leverage and credit risk. However, the negative profitability metrics and high price-to-book ratio suggest that the company may be vulnerable to market volatility or changes in investor sentiment. The company's dilution risk is also low, as there are no indications of recent or planned share issuances that could dilute existing shareholders. Recent events related to the company are not detailed in the input data. The company's financial statements and risk assessment do not mention any recent filings, transcripts, or other events that could impact its operations or financial position. The company's investment manager, Octopus Investments Limited, is responsible for managing the portfolio, but there is no information on recent changes in management or investment strategy.

30-day price · OOA+2.46 (+6.7%)
Low$35.00High$39.90Close$39.20As of13 May, 00:00 UTC
Profile
CompanyOctopus AIM VCT PLC
TickerOOA.L
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. Octopus AIM VCT PLC is a United Kingdom-based venture capital trust that invests in a broad range of Alternative Investment Market (AIM) or Aquis Stock Exchange (AQSE) traded companies to provide shareholders with tax-free dividends and long-term capital growth.

Classification. Octopus AIM VCT PLC is classified under the Financials economic sector, Banking & Investment Services business sector, and Investment Management & Fund Operators industry, with a classification confidence of 0.92.

The company maintains a strong liquidity position, with a current ratio of 7.11, indicating that it has significantly more current assets than current liabilities. It holds £18.2 million in cash and equivalents, which supports its liquidity profile. However, the company's price-to-book ratio is 86.0, suggesting that the market value is significantly higher than the book value, which may reflect investor sentiment or speculative positioning. Profitability metrics are negative, with a return on equity of -5.27% and a return on assets of -5.03%. These figures indicate that the company is not generating returns for its shareholders and is underperforming relative to industry norms. The company's operating and net income are both negative, at -£6.08 million, which suggests that it is not currently profitable and is likely relying on capital gains or other non-operational sources to sustain its operations. The company's revenue is reported as negative (-£3.35 million), which is unusual and may indicate a reporting anomaly or a specific accounting treatment. The company's investment portfolio spans multiple sectors, including software and computer services, pharmaceuticals and biotechnology, and telecommunications service providers, among others. However, the input data does not provide specific revenue concentration figures, so it is unclear whether the company has significant exposure to any particular segment or geographic region. The company's growth trajectory is not clearly defined in the input data, as there are no forward-looking revenue projections or historical growth rates provided. The company's current financial performance is negative, and there is no indication of a turnaround in the near term. The company's investment strategy is focused on long-term capital growth, but the current financial results suggest that it is not achieving this objective. The company's risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company has no long-term debt, which reduces its financial leverage and credit risk. However, the negative profitability metrics and high price-to-book ratio suggest that the company may be vulnerable to market volatility or changes in investor sentiment. The company's dilution risk is also low, as there are no indications of recent or planned share issuances that could dilute existing shareholders. Recent events related to the company are not detailed in the input data. The company's financial statements and risk assessment do not mention any recent filings, transcripts, or other events that could impact its operations or financial position. The company's investment manager, Octopus Investments Limited, is responsible for managing the portfolio, but there is no information on recent changes in management or investment strategy.
Key takeaways
  • The company has a strong liquidity position, with a current ratio of 7.11 and £18.2 million in cash and equivalents.
  • The company is not currently profitable, with negative operating and net income of -£6.08 million.
  • The company's return on equity and return on assets are both negative, indicating poor performance relative to industry norms.
  • The company's price-to-book ratio is 86.0, suggesting that the market value is significantly higher than the book value.
  • The company's risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected.
  • The company's growth trajectory is not clearly defined, and there is no indication of a turnaround in the near term.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue-$3.3M
Gross profit-$5.5M
Operating income-$6.1M
Net income-$6.1M
R&D
SG&A
D&A
SBC
Operating cash flow$358.0k
CapEx
Free cash flow
Total assets$120.9M
Total liabilities$5.5M
Total equity$115.4M
Cash & equivalents$18.2M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$39.60
Market cap$9.92B
Enterprise value$9.90B
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF27665.9
P/B86.0
P/Tangible book86.0
Tangible book$115.4M
Net cash$18.2M
Current ratio7.1
Debt/Equity0.0
ROA-5.0%
ROE-5.3%
Cash conversion-6.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Banking & Investment Services · cohort 10 companies
MetricOOAActivity
Op margin181.6%26.6% medp25 13.9% · p75 29.0%top quartile
Net margin181.6%18.8% medp25 13.7% · p75 22.7%top quartile
Gross margin163.9%67.6% medp25 41.5% · p75 93.2%top quartile
CapEx / revenue1.2% medp25 0.4% · p75 1.9%
Debt / equity0.0%7.7% medp25 7.7% · p75 7.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 14:05 UTC#d99290b4
Market quoteclose GBP 39.60 · shares 0.25B diluted
no public URL
2026-05-10 14:05 UTC#385536d0
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 14:06 UTCJob: 36481de6